Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
US11266720B2 · kind B2 · utility
4Cited by
41References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2019 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Jul 21, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of administering Factor VIII; methods of administering chimeric and hybrid polypeptides comprising Factor VIII; chimeric and hybrid polypeptides comprising Factor VIII; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.